Impella 2.5 System; Impella CP System; Impella CP with Smart Assist System; Impella 5.0 System, Impella 5.5 with Smart A
Abiomed, Inc. · Decision date Feb 6, 2026
What did the FDA approve?
FDA records P140003/S135 as a supplement to PMA P140003, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Feb 6, 2026.
FDA approval order statement
approval for a modification to the Instructions for Use to allow sodium bicarbonate to be used in the purge fluid for the Impella catheters if heparin should not be used per the physicians clinical judgement.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 6, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P140003/S135
- Regulatory pathway
- PMA supplement
- Applicant
- Abiomed, Inc.
- Product code
- OZD
- Decision code
- APPR
- Decision date
- Feb 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Temporary non-roller type left heart support blood pump.
- Applicant
- Abiomed, Inc.
- Product code
- OZD
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P140003/S128 · Related supplement
Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD
P140003/S123 · Related supplement
Impella 5.5 with SmartAssist System; Impella CP with SmartAssist System; Impella 2.5; Impella 5.0; Impella LD;
P140003/S124 · Related supplement
Impella CP with SmartAssist System
P140003/S126 · Related supplement
Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge Cassette
P140003/S129 · Related supplement
Impella 2.5; Impella CP; Impella CP with SmartAssist; Impella 5.0; Impella 5.5 with SmartAssist; Impella LD
P140003/S130 · Related supplement
Impella CP with SmartAssist
P140003/S131 · Related supplement
Impella 5.5 with SmartAssist
P140003/S135 received
Application receipt date recorded by FDA.
P140003/S136 · Related supplement
Impella CP with SmartAssist; Impella 5.5 with SmartAssist
P140003/S135 · FDA decision
Real-Time Process
P140003/S137 · Related supplement
Impella 5.5 with Smart Assist
P140003/S138 · Related supplement
Impella CP with SmartAssist
Timeline entries are records held by MedtechLedger for P140003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abiomed, Inc. | PMA supplement | Jul 25, 2025 | FDA | |
| Abiomed, Inc. | PMA supplement | Aug 1, 2025 | FDA | |
Impella CP with SmartAssist SystemP140003/S124 | Abiomed, Inc. | PMA supplement | Aug 8, 2025 | FDA |
| Abiomed, Inc. | PMA supplement | Sep 15, 2025 | FDA | |
| Abiomed, Inc. | PMA supplement | Sep 19, 2025 | FDA | |
Impella CP with SmartAssistP140003/S130 | Abiomed, Inc. | PMA supplement | Sep 24, 2025 | FDA |
Impella 5.5 with SmartAssistP140003/S131 | Abiomed, Inc. | PMA supplement | Oct 1, 2025 | FDA |
| Abiomed, Inc. | PMA supplement | Dec 19, 2025 | FDA | |
Impella 5.5 with Smart AssistP140003/S137 | Abiomed, Inc. | PMA supplement | Apr 7, 2026 | FDA |
Impella CP with SmartAssistP140003/S138 | Abiomed, Inc. | PMA supplement | Jun 15, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abiomed, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 22 Cherry Hill Dr., Danvers, MA, 01923
Sources and methodology
- Original FDA record: P140003/S135
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





